SerenoCem Granules BCG050 (Orthopaedic bone cement) 의 리콜

Recall

RC-2016-RN-00439-1

Class II

2016-07-12

Australia

DHTGA

https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2016-RN-00439-1

The manufacturer, corinthian surgical ltd has been made aware of a cluster of cases in the united kingdom where it has been observed that there has been some bone re- absorption in the area adjacent to the granules in the middle ear. this can lead to exposure of the dura and facial nerve, potentially resulting in infection and/or brain herniation. as a precautionary measure corinthian surgical ltd is temporally suspending the supply of serenocem granules and there should be no further use of the granules at this time. the cause of the reported cases of bone resorption is currently under investigation.

Endotherapeutics is recommending that if a patient presents for a routine checkup or at the 2 yearly follow up, to perform a CT scan. Outside of these circumstances, patients should undergo a CT scan at the clinical discretion of the treating surgeon. Any remaining unused stock should be quarantined and returned to Endotherapeutics. The investigation is currently ongoing, and further communications may be required following completion of the investigation and in consultation with the Therapeutic Goods Administration (TGA).